Loading…
← CockpitCompetitor Analysis › ASRNL.AS ASR Nederland N.V.Open in the cockpit ↗

ASR Nederland N.V.ASRNL.ASCompetitor analysis, valuation and peers

Netherlands · EUR·Financials›Multi-Line Insurance

Dutch insurer offering non-life, life insurance and pensions, formed from the former state-owned insurer.

≈ A Dutch Progressive/MetLife hybridMomentum strong 77
Mkt cap
$17.3B
US dollars, full cap
Free float
100%
of shares outstanding
$/day
$32.3M
20-day average traded
P/B
1.74×
price to book
ROE
13.2%
delivered
Implied ROE
8.3%
what the price asks
Next earnings
103 days
17 Feb 2027
Close · EUR€77.26
1D-1.4%
1W+2.1%
1M+8.3%
3M+9.6%
6M+13.9%
YTD+27.4%
1Y+33.0%
ATR %1.4%
52w lowhigh2.2% off high

What ASR Nederland does

Dutch insurer offering non-life, life insurance and pensions, formed from the former state-owned insurer.

Earns from the gap between premiums collected and claims paid, plus returns on the investments held against future claims, with fees on pension management. Buying Aegon's Dutch business in 2023 made it one of the Netherlands' largest life and pension insurers, and left Aegon as a significant minority shareholder.

In one line: A Dutch Progressive/MetLife hybrid.

Products and services

  • Non-life/P&C insurance
  • Life insurance
  • Pensions

Customers

  • Retail policyholders
  • Corporate pension clients
  • SMEs

Where it sits in the supply chain

  • Insurance
  • Composite insurer
  • Non-life, life & pension products

What could go right

  • Pension consolidation in Netherlands
  • Non-life pricing discipline

What could go wrong

  • Low interest rate margin pressure
  • Weather-related claims volatility

Moat: narrow (scale, distribution, brand). Established Dutch distribution (brokers/banks) and scale in a mature, consolidated home market.

Headquarters: Utrecht, Netherlands · Founded: 1720 · Employees: 9,718

Named competitors

ASR Nederland at a glance

Size ASR Nederland (ASRNL.AS) is a Netherlands Financials company (Multi-Line Insurance) with a market value of $17.3B, the 17th largest of 61 Netherlands companies the cockpit tracks. Shares closed at €77.26 on 6 Nov 2026.

Performance Over six months the shares gained 13.9%, against +8.4% for the median peer and +0.4% for the Netherlands market (cap-weighted) — 8th highest of 21 in its peer set.

Growth Revenue grew 6.1% over the last twelve months (peer median +7.9%); the operating margin is 41.9% (peer median 9.4%).

Valuation It trades at 1.74× book value against a peer median of 1.78× (10th cheapest of 21).

Price implies The share price implies a return on equity of about 8.3%; ASR Nederland delivers 13.1%, so the price asks less than the business earns today.

Next results Next results expected around 17 Feb 2027 (exchange calendar; dates can move).

Relative performance

10011011 May 202611 Aug 20266 Nov 2026ASRNL.AS 114Peer median 110
Six months, rebased to 100: ASR Nederland against the median of its 20 peers (local-currency closes).

ASR Nederland financials

Reported figures in EUR; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue€20.5B€21.2B€16.4B€12.8B€19.4B
Revenue growth—+30%+28%-34%—
Net income€1.14B€475M€895M€1.04B-€1.76B
Free cash flow€1.34B-€587M-€724M€3.57B-€1.14B
Capital expenditure€51.0M€32.0M€30.0M€34.0M€190M
Total debtn/a€10.4B€11.7B€13.9B€3.20B

Quarterly statements and history in the cockpit →

ASR Nederland competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%-10%0%+10%PZUBNTSUNGJFMAP1336LGENCNAAGNUNIUNMGLABCAPITALHBANWRBCINFAV2378PUKKNSLASRNL.AS6-month return →1-month return →
Up and to the right = strong over both horizons. ASR Nederland is the large dot.

Fundamentals: return on equity against price-to-book

10%20%30%20×40×60×PZUBNTSUNGJFMAP1336LGENCNAAGNUNIUNMGLABCAPITALHBANWRBCINFAV2378KNSLASRNL.ASReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. ASR Nederland is the large dot.

Capital: ROE delivered against the ROE the price implies

0%20%40%60%0%20%40%60%PZUBNTSUNGJFMAP1336LGENCNAUNIUNMABCAPITALCINFAV2378KNSLASRNL.ASROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. ASR Nederland is the large dot.

ASR Nederland competitors and peer comparison

Head to head with its named competitors (ASRNL.AS vs NN.AS vs AGN.AS vs ALV.DE)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
ASR Nederland ASRNL.AS$17.3B+14%+6%13%1.74×8.3%
NN Group N.V. NN.AS$22.4B+4%+39%9%1.08×6.9%
Aegon AGN.AS$12.7B+4%+16%10%1.25×8.2%
Allianz ALV.DE$192B+19%+21%21%2.98×16.0%

How ASR Nederland compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

ASR Nederland against its 20 peers (data as of 6 Nov 2026)
MeasureASRNL.ASPeer medianRank in peer set
1-month return+8.3%+4.0%7th highest of 21
6-month return+13.9%+8.4%8th highest of 21
Return on equity13.2%16.9%10th lowest of 21
Price / book1.74×1.78×10th cheapest of 21
Trailing P/E14.6×12.5×10th most expensive of 20
ROE the price implies8.3%11.6%5th least demanding of 21
ROE delivered13.1%16.9%10th lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
ASR Nederland ASRNL.ASNetherlands$17.3B+14%+6%13%1.74×8.3%13.1%
Powszechny Zaklad Ubezpieczen Spolka Akcyjna PZU.WAPoland$16.1B+15%+1%20%1.83×19.5%19.5%
Brookfield Wealth Solutions BNT.TOCanada$14.9B-8%-18%1%0.70×9.4%0.7%
Suncorp SUN.AXAustralia$14.9B+21%-3%10%2.08×11.7%9.8%
Gjensidige Forsikring GJF.OLNorway$14.7B+9%+7%30%5.73×19.1%29.9%
Mapfre MAP.MCSpain$14.1B-2%+5%12%1.26×8.4%12.4%
New China Life Insurance 1336.HKHong Kong$21.5B-24%+44%42%0.87×10.3%42.3%
Legal & General LGEN.LUnited Kingdom$21.9B+24%+137%26%7.73×70.7%26.2%
CNA Financial CNAUnited States$12.8B+9%+2%10%1.25×7.2%9.6%
Aegon AGN.ASNetherlands$12.7B+4%+16%10%1.25×8.2%10.5%
Unipol Assicurazioni UNI.MIItaly$23.8B+13%+7%17%1.62×14.9%16.9%
Unum UNMUnited States$12.2B-5%-5%3%1.52×8.1%2.6%
Globe Life GLUnited States$12.1B+4%+6%21%2.08×11.7%n/a
Aditya Birla Capital ABCAPITAL.NSIndia$11.5B+8%+24%12%2.56×41.9%12.1%
Helvetia Baloise HBAN.SWSwitzerland$27.0B+5%+54%4%1.80×4.8%4.0%
W. R. Berkley WRBUnited States$27.9B+16%+1%19%2.91×12.8%19.2%
Cincinnati Financial CINFUnited States$28.5B+15%+10%17%1.76×10.6%16.9%
Aviva AV..LUnited Kingdom$29.5B+18%+86%7%2.46×23.8%6.8%
Prudential 2378.HKHong Kong$30.8B-24%+30%19%1.54×11.3%19.3%
Prudential plc Sponsored ADR PUKUnited States$31.7B-21%+39%19%1.56×11.4%19.2%
Kinsale Capital KNSLUnited States$8.64B+26%+8%28%4.70×30.6%27.8%

Questions

Who are ASR Nederland's main competitors?
Named competitors: NN Group (NN.AS), Aegon (AGN.AS), Achmea (private) (private or unlisted), Allianz (ALV.DE). The cockpit's measured peer set (industry) also includes Powszechny Zaklad Ubezpieczen Spolka Akcyjna (PZU.WA), Brookfield Wealth Solutions (BNT.TO), Suncorp (SUN.AX), Gjensidige Forsikring (GJF.OL), Mapfre (MAP.MC), New China Life Insurance (1336.HK).
Is ASR Nederland expensive compared with its peers?
On price / book it trades at 1.74× against a peer median of 1.78×, 10th cheapest of 21 in its peer set. The share price implies a return on equity of about 8.3%; ASR Nederland delivers 13.1%, so the price asks less than the business earns today.
How has ASR Nederland stock performed?
Over six months to 6 Nov 2026 the shares returned +13.9% against +8.4% for the median peer; over one year +33.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.